The Filing Desk

Pro Dex vs Sight Sciences

Pro Dex PDEX · Sight Sciences SGHT · Health Care Equipment

Pro Dex reported revenue of $78 million in fiscal 2026, about the same as Sight Sciences' $77 million in fiscal 2025. Pro Dex's revenue grew 16.4% in its latest year, and Sight Sciences' fell 3.1%. Pro Dex had an operating margin of 16.8%, against -48.0% at Sight Sciences. Free cash flow was $7 million at Pro Dex and −$30 million at Sight Sciences. Their fiscal years end in different months (June 30 and December 31), so the periods don't line up exactly.

Side by side

Pro DexSight Sciences
Latest fiscal yearFY2026, Jun 30, 2026FY2025, Dec 31, 2025
Revenue$78M$77M
Revenue growth16.4%−3.1%
Revenue growth a year, last 5 years15.3%22.9%
Gross margin31.4%86.2%
Operating margin16.8%−48.0%
Net margin17.6%−49.7%
Free cash flow$7M−$30M
Free cash flow margin8.7%−38.7%
Return on capital19.6%—
Net debt to EBITDA0.6x—
Dividends and buybacks$3M$0M
Change in diluted share count−1.3%4.0%
Last close$63.49$10.62
P/E at the last close17.5×—
Insider trades, last 12 monthssold $2.0 millionbought $184,799, sold $2.3 million
Piotroski F-score7 of 95 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Pro DexSight Sciences
Operating margin
Percent of revenue
Pro DexSight Sciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Pro DexSight Sciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Pro Dex and Sight Sciences pages.